GlassScriptPhysician profile
William J Schoen
NPI 1619920998
$4,766.51
in general payments reported to CMS, 2019-2025
33 companies · $566 in 2025
The $566 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,042 · 2020: $468 · 2021: $843 · 2022: $625 · 2023: $440 · 2024: $782 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,323.17 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, General - Therapies |
| Janssen Pharmaceuticals, INC | $499.55 | 2019-2023 | Xarelto |
| Biosense Webster, INC. | $378.85 | 2019-2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $371.25 | 2019-2025 | Lifevest |
| Pfizer INC. | $260.88 | 2019-2025 | |
| Abbott Laboratories | $243.94 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $206.68 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $196.42 | 2019-2020 | |
| Medtronic Vascular, INC. | $192.06 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $160.00 | 2023-2024 | Camzyos, Eliquis |
| Medtronic, INC. | $134.32 | 2021-2024 | Endurant Iis |
| Sensible Medical Innovations INC | $92.11 | 2021 | |
| Cardiofocus, INC. | $91.10 | 2019 | |
| Baxter Healthcare | $79.72 | 2022-2023 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74.94 | 2021-2024 | Jardiance |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $68.35 | 2019-2022 | |
| Penumbra, INC. | $50.97 | 2025 | Penumbra System |
| Lundbeck LLC | $35.51 | 2019-2021 | |
| Atricure, INC. | $30.87 | 2022-2025 | Atriclip Laa Exclusion System |
| Actelion Pharmaceuticals US, INC. | $29.81 | 2019 | |
| Chiesi USA, INC. | $28.08 | 2019-2020 | |
| Preventice Services, LLC | $27.23 | 2021 | |
| Elutia, INC. | $26.79 | 2019-2020 | |
| Amarin Pharma, INC. | $23.75 | 2019 | |
| Abiomed | $20.64 | 2024 | Impella |
| Molnlycke Health Care US, LLC | $19.69 | 2020 | |
| Shockwave Medical, INC | $19.60 | 2025 | |
| Novo Nordisk INC | $18.94 | 2019 | |
| Esperion Therapeutics, INC. | $18.27 | 2021 | |
| Amgen INC. | $16.26 | 2021 | |
| Philips North America LLC | $16.18 | 2022 | |
| Cardiovascular Systems INC. | $7.03 | 2019 | |
| Bardy Diagnostics, INC. | $3.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Schoen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.